Are statins anti-inflammatory? Issues in the design and conduct of the pravastatin inflammation C-reactive protein evaluation Paul M. Ridker Clinical Trials Review Pages: 269 - 273
The role of C-reactive protein in cardiovascular disease risk Michelle A. Albert OriginalPaper Pages: 274 - 279
Weighing the evidence for infection as a risk factor for coronary heart disease Christopher J. O'DonnellDaniel Levy OriginalPaper Pages: 280 - 287
Hormone replacement therapy and cardiovascular risk Marie Gerhard-HermanNaomi HamburgPeter Ganz OriginalPaper Pages: 288 - 292
Beta-carotene, vitamin C, and vitamin E and cardiovascular diseases Gilles R. DagenaisRoberto MarchioliSalim Yusuf OriginalPaper Pages: 293 - 299
Imaging techniques to predict cardiovascular risk Michael V. McConnell OriginalPaper Pages: 300 - 307
Prophylactic defibrillator implantation in patients with coronary artery disease Peter A. O'Callaghan Clinical Trials Review Pages: 311 - 313
Radiofrequency catheter ablation of atrial fibrillation initiated by spontaneous ectopic beats Shih-Ann ChenChing-Tai TaiMau-Song Chang OriginalPaper Pages: 322 - 328
The utility of intracardiac echocardiography in interventional electrophysiology Laurence M. Epstein OriginalPaper Pages: 329 - 334
Implantable dual-chamber cardioverter-defibrillator-pacemaker Dietrich PfeifferMaika MendeAndreas Hagendorff OriginalPaper Pages: 335 - 340
Are implantable cardioverter-defibrillators cost-effective? Ajay M. NaikC. Thomas Peter OriginalPaper Pages: 341 - 345
Methods of minimizing inappropriate implantable cardioverter-defibrillator shocks Beat SchaerStefan Osswald OriginalPaper Pages: 346 - 352
Emerging indications for permanent pacing Deborah L. WolbretteGerald V. Naccarelli OriginalPaper Pages: 353 - 360
